|
Match
|
Document |
Document Title |
|
|
7585858 |
N-sulfonylcarboximidamide apoptosis promoters
Compounds having the formula
are apoptosis promoters. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
|
|
|
7579346 |
Carboxamides
Novel compounds of the formula (I), in which D, W, X, Y, T, m and R 1 have the meaning indicated in Patent claim 1 , are inhibitors of coagulation factor Xa and can be employed for the...
|
|
|
7579340 |
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.
|
|
|
7528136 |
Prolinamide derivatives as NK3 antagonists
The present invention relates to a compound of formula I
wherein
R 1 , R 2 , R 3 , R 4 , R 5 , X, n, and o are as defined herein and to a pharmaceutically acceptable acid addition salt thereof...
|
|
|
7521473 |
Inhibitors of protein tyrosine phosphatase 1B
Protein tyrosine phosphatases (PTPases) such as PTP1B can play a role in regulating a wide variety of cellular responses such as insulin signaling. Substituted thiophene compounds such as, for...
|
|
|
7446195 |
High affinity thiophene-based and furan-based kinase ligands
Inhibitors of cyclin dependent kinase 2, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions...
|
|
|
7427632 |
Factor Xa inhibitors
Compounds of formula (I)
in which R 1 , n, Z, R 3 and R 4 have any of the meanings given in the specification, are inhibitors of the serine protease Factor Xa and are useful in the treatment...
|
|
|
7396944 |
Thiophene derivatives, their manufacture and use as pharmaceutical agents
Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the...
|
|
|
7381721 |
Substituted piperidine compounds
3,4-Disubstituted-4-aryl-piperidine compounds are disclosed. Pharmaceutical compositions containing the 3,4-disubstituted-4-aryl-piperidine compounds and methods of their pharmaceutical uses are...
|
|
|
7365196 |
Sulphonamido-substituted bridged bicycloalkyl derivatives
A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of...
|
|
|
7361666 |
Heterocyclic analgesic compounds and methods of use thereof
One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various...
|
|
|
7335670 |
Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics
Compounds of formula (I) as defined herein:
are useful for treating behavioral disorders associated with dementia, psychoses, in particular schizophrenia (deficient form and productive form)...
|
|
|
7326716 |
Treatment of inflammatory bowel disease
The present invention provides a method of treating inflammatory bowel disease which comprises administering to an animal having ocular hypertension or glaucoma therapeutically effective amount of...
|
|
|
7288538 |
Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists
The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.
|
|
|
7259157 |
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
Compounds represented by Formula (I):
or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.
|
|
|
7226933 |
4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
Compounds of general formula I
R 1 is selected from any one of phenyl, pyridinyl, pyrrolyl, thienyl, furanyl, imidazolyl, triazolyl, and pyridine N-oxide; where each R 1 phenyl ring and R 1 ...
|
|
|
7173129 |
Sulfonamide-substituted chalcone derivatives and their use to treat diseases
The invention relates to compounds, pharmaceutical compositions and methods of using compounds of the general formula
or its pharmaceutically acceptable salt or ester, wherein the substituents...
|
|
|
7125895 |
Cyclic amine derivatives and their uses
This invention relates to novel arylalkyl cyclic amine derivatives. This invention also relates to chemokine receptor antagonists that are be effective as therapeutic agents and/or preventive...
|
|
|
6984637 |
Cyclic amine derivatives-CCR-3 receptor antagonists
This invention relates to certain cyclic amine derivatives of Formula (I)
that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods...
|
|
|
6960602 |
Piperidine derivatives as modulators of chemokine receptors
The invention provides a compound of formula (I): wherein R 1 , R 2 , R 3 , R 3a , R 4 , R 4a , R 5 , and R 6 are as defined; or a pharmaceutically acceptable salt thereof or a solvate thereof;...
|
|
|
6903119 |
Amino acid derivatives and drugs containing the same as the active ingredient
The present invention relates to the compounds of the formula (I) and salts thereof (all the symbols are the same meanings as described in the specification).
The compounds of the formula (I)...
|
|
|
6890928 |
Aromatic sulfone hydroxamic acids and their use as protease inhibitors
This invention is directed to aromatic sulfone hydroxamic acids (including hydroxamates) and salts thereof that, inter alia, inhibit matrix metalloproteinase (also known as “matrix...
|
|
|
6887871 |
Use of phenylheteroakylamine derivatives
There is disclosed the use of a compound of formula (I) wherein R 1 , R 2 , X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts, enantiomers or racemates...
|
|
|
6864249 |
Piperidine and azetidine thrombin inhibitors
The present invention relates to a compound having formula I:
and pharmaceutically acceptable salts thereof. The compounds of formula I and pharmaceutical compositions containing them are of...
|
|
|
6861530 |
Piperidine derivatives
This invention relates to substituted piperidine derivatives having at least one six-membered ring substituent. The piperidine derivatives exhibit antitumor activity and are useful as...
|
|
|
6841682 |
Heterocycles useful in the treatment of benign prostatic hyperplasia
This invention relates a to a series of heterocyclic substituted piperazines of Formula I
pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds...
|
|
|
6828318 |
2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
Compounds of formula (1): wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are independently selected from hydrogen, alkyl, aryl and non-aromatic heterocyclic groups, or each of one or more pair(s)...
|
|
|
6787650 |
Urea compounds, process for producing the same and use thereof
A compound of the formula: [wherein R 1 is a hydrocarbon group which may be substituted; R 2 is a cyclic hydrocarbon group which may be substituted or a heterocyclic group which may be...
|
|
|
6756387 |
Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
Compounds of general formula I R 1 is selected from any one of phenyl, pyridinyl, thienyl, furanyl, imidazolyl, triazolyl and thiazolyl; where each R 1 phenyl ring and R 1 heteroaromatic ring...
|
|
|
6753335 |
Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
Compounds of general formula I R 1 is selected from any one of phenyl, pyridinyl, thienyl, furanyl, imidazolyl, and triazolyl; where each R 1 phenyl ring and R 1 heteroaromatic ring may...
|
|
|
6710060 |
4-hydroxypiperidine derivatives having antiarrhythmic activity
The present invention relates to a compound represented by the following formula (I) or a salt thereof, or a pharmaceutical composition containing the compound as an effective ingredient: ...
|
|
|
6696234 |
Silver halide photosensitive material and isothiazolidine-3-one derivative
A silver halide photosensitive material contains a compound of the following general formula (I): wherein A 1a represents a group selected from among CR 1a R 2a , NR 1a , an oxygen atom and...
|
|
|
6689794 |
Aromatic sulfone hydroxamates and their use as protease inhibitors
This invention is directed to aromatic sulfone hydroxamates (also known as “aromatic sulfone hydroxamic acids”) and salts thereof that, inter alia, inhibit matrix metalloproteinase (also known...
|
|
|
6664273 |
Piperidine based MCH antagonists for treatment of obesity and CNS disorders
The present invention discloses compounds, which are novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In another embodiment, the invention...
|
|
|
RE38257 |
Piperdine derivatives and hypotensives containing the same
A piperidine compound of the formula (I): wherein A is a fused aromatic ring; R is hydrogen, chloro or methoxy; X is (CH 2 ) n , which may be substituted, in which n is 0 or an integer of 1 to...
|
|
|
6617325 |
Biphenyl derivatives, production thereof and uses as medicines
The present invention relates to biphenyl derivatives of general formula wherein R a to R g and n are defined as in claim 1, the isomers and salts thereof, particularly the physiologically...
|
|
|
6528532 |
Urea derivatives as HIV aspartyl protease inhibitors
The present invention provides HIV aspartyl protease inhibitors of the formula: and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof,...
|
|
|
6451797 |
Muscarinic antagonists
Heterocyclic derivatives of di-N-substituted piperazine or 1,4 di-substituted piperidine compounds in accordance with formula I (including all isomers, salts and solvates) wherein wherein one of...
|
|
|
6303637 |
Heterocyclic potassium channel inhibitors
The present invention relates to a class of heterocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like....
|
|
|
6288085 |
Piperidine derivatives for treating psychoses
The present invention relates to certain novel piperidine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy,...
|
|
|
6265433 |
LTA4 hydrolase inhibitors
The present invention provides compounds having the structure: ##STR1## and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases...
|
|
|
6262044 |
Modulators of protein tyrosine phosphatases (PTPASES)
The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein...
|
|
|
6197791 |
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
Matrix metalloproteinases (MMPs) are a group of enzymes that have been implicated in the pathological destruction of connective tissue and basement membranes. These zinc containing endopeptidases...
|
|
|
6174900 |
Substituted piperidine derivative for treating urinary disturbance
Disclosed herein is a substituted piperidine derivative represented by the following general formula (1): ##STR1## wherein R 1 means an aryl or heteroaryl group which may have at least one...
|
|
|
6083943 |
Substituted azaheterocyclecarboxylic acid
A compound of the chemical formula (I) and its pharmaceutically acceptable salt: ##STR1## wherein Y is C 2 -C 4 alkylene; Z is a valence bond or C 1 -C 6 alkylene; R 1 is substituted or...
|
|
|
6066650 |
Inhibitors of microsomal triglyceride transfer protein and method
Compounds are provided which inhibit microsomal triglyceride transfer protein and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases. The compounds have the...
|
|
|
6013656 |
2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors
New 2-(arylalkenyl)azacycloalkane derivatives which are ligands for sigma receptors, of the formula (I) ##STR1## in which: Ar is aryl or heteroaryl, optionally mono- to trisubstituted, m has the...
|
|
|
6008223 |
Therapeutic compounds
Compounds of formula I ##STR1## wherein Q 1 , Q 2 , Q 3 , and Q 4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide...
|
|
|
5968956 |
Substituted piperidine derivative and medicine comprising the same
Disclosed herein is a substituted piperidine derivative represented by the following general formula (1): ##STR1## wherein R 1 means an aryl or heteroaryl group which may have at least one...
|
|
|
5948792 |
Fluorine-containing 1,4-disubstituted piperidine derivatives
Novel fluorine-containing 1,4-disubstituted piperidine derivatives, represented by general formula I! ##STR1## such as, for example, (2R)-N- 1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl!-2-...
|